YGIX MEDICINES
Live / Allowed — Published for opposition (as of 17 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Jun 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99240832
- Mark type
- Design + words
- Filed
- 18 Jun 2025
- Published for opposition
- 17 Mar 2026
- Attorney of record
- John J. O'Malley
Goods and services
- Class 005 — Pharmaceuticals: (Based on 44(d) Priority Application) Pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in humans (Based on Intent to Use) Veterinary pharmaceutical preparations for the treatment of oncological, hematological, immunological, neurological, cardiovascular, metabolic, infectious, inflammatory, dermatological, gastrointestinal, hepatic, respiratory, renal, ophthalmic, and musculoskeletal diseases and disorders in animals
- Class 042 — Scientific and technological services: (Based on 44(d) Priority Application) Pharmaceutical research services; Pharmaceutical product evaluation; Research of pharmaceuticals; Pharmaceutical research and development; Research relating to pharmaceuticals; Pharmaceutical research and development services; Research on the subject of pharmaceuticals; Laboratory research services relating to pharmaceuticals; Research and development for the pharmaceutical industry; Consultancy in the field of pharmaceutical research; Consultancy relating to pharmaceutical research and development; Laboratory research in the field of pharmaceuticals; Technical research in the field of pharmaceutical studies; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical products development; Pharmaceutical drug development services; Development of pharmaceutical preparations and medicines; Preparation of scientific research reports in the biotechnology field; Consultancy in the field of biotechnology; Consultancy relating to biotechnology; Biotechnology testing services; Biotechnology research; Research relating to biotechnology; Scientific consultancy services relating to pharmaceutical and biotechnology research and development; Scientific analysis services in the field of pharmaceuticals and biotechnology; Scientific services, namely, scientific laboratory services, scientific research and analysis services in the field of pharmaceuticals and biotechnology; Scientific research; Scientific testing services, namely, testing of pharmaceuticals for scientific research purposes; Scientific research services; Scientific advisory services relating to pharmaceutical and biotechnology development; Scientific research consulting; Scientific laboratory services (Based on Intent to Use) Veterinary research; Veterinary laboratory services being veterinary research laboratories
- Class 044 — Medical, beauty and agricultural services: (Based on 44(d) Priority Application) Pharmaceutical consultation; Pharmaceutical advice; Pharmaceutical advisory services; Provision of pharmaceutical information; Medical consultancy and information services relating to pharmaceutical products (Based on Intent to Use) Veterinary advisory services; Providing veterinary information; Information services relating to veterinary pharmaceuticals; Veterinary laboratory services in the nature of veterinary analysis services for diagnostic and treatment purposes provided by veterinary laboratories
- Class 045 — Legal and security services: Intellectual property consultation; Intellectual property consultancy; Protection of intellectual property, namely, intellectual property licensing services and intellectual property rights management; Intellectual property services, namely, intellectual property consultancy services and intellectual property licensing services; Intellectual property licensing services; Management of intellectual property; Licensing of intellectual property; Licensing of intellectual property rights; Consultancy relating to intellectual property management; Intellectual property management services; Advisory services relating to intellectual property rights; Consultancy relating to the licensing of intellectual property; Intellectual property consultancy services for universities and research institutions
Owner
- YGIX Medicines Limited, Dublin, IE
- YGIX Medicines Limited, Dublin, IE
Prosecution history
- 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2026 — PUBLISHED FOR OPPOSITION
- 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 18 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 12 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 12 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 12 Nov 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Nov 2025 — NON-FINAL ACTION E-MAILED
- 12 Nov 2025 — NON-FINAL ACTION WRITTEN
- 06 Nov 2025 — ASSIGNED TO EXAMINER
- 25 Oct 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 25 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 18 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 18 Jun 2025 — NEW APPLICATION ENTERED